Cargando…

A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models

SIMPLE SUMMARY: 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) is responsible for the production of estrogens estradiol (E2) and 5-androsten-3β,17β-diol (5-diol). This enzyme is therefore a target of choice for the treatment of estrogen-dependent diseases such as breast cancer and endometriosis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poirier, Donald, Roy, Jenny, Maltais, René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069897/ https://www.ncbi.nlm.nih.gov/pubmed/33924352 http://dx.doi.org/10.3390/cancers13081841

Ejemplares similares

Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol
por: Maltais, René, et al.
Publicado: (2011)

Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone
por: Ngueta, Adrien Djiemeny, et al.
Publicado: (2023)

Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models
por: Kenmogne, Lucie Carolle, et al.
Publicado: (2017)

The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers
por: Kenmogne, Lucie Carolle, et al.
Publicado: (2015)

An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models
por: Poirier, Donald, et al.
Publicado: (2023)

Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel
por: Maltais, René, et al.
Publicado: (2021)

Characterization of 17α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone
por: Bellemare, Véronique, et al.
Publicado: (2005)

New Insights into Testosterone Biosynthesis: Novel Observations from HSD17B3 Deficient Mice
por: Lawrence, Ben M., et al.
Publicado: (2022)

BMX controls 3βHSD1 and sex steroid biosynthesis in cancer
por: Li, Xiuxiu, et al.
Publicado: (2023)

Functional genetic variant of HSD17B12 in the fatty acid biosynthesis pathway predicts the outcome of colorectal cancer
por: Lin, Yu, et al.
Publicado: (2020)

HSD47 Malignant Surgical Volumes and Length of Stay By Modality during the COVID-19 Pandemic
por: Wing, S, et al.
Publicado: (2022)

THU574 Hsd17b1 Partially Compensates For The Lack Of Hsd17b3 In Testicular Testosterone Production In Fetal Mice, But Not In Adults
por: Poutanen, Matti, et al.
Publicado: (2023)

Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses
por: Mohamed, Bassim, et al.
Publicado: (2020)

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
por: Spadaro, Alessandro, et al.
Publicado: (2012)

HSD17B13: A Potential Therapeutic Target for NAFLD
por: Zhang, Hai-bo, et al.
Publicado: (2022)

Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
por: Burguin, Anna, et al.
Publicado: (2023)

In vivo Characterization of Plasmodium berghei P47 (Pbs47) as a Malaria Transmission-Blocking Vaccine Target
por: Yenkoidiok-Douti, Lampouguin, et al.
Publicado: (2020)

Synthesis of 5α-Androstane-17-spiro-δ-lactones with a 3-Keto, 3-Hydroxy, 3-Spirocarbamate or 3-Spiromorpholinone as Inhibitors of 17β-Hydroxysteroid Dehydrogenases
por: Djigoué, Guy Bertrand, et al.
Publicado: (2013)

SUN-213 Hsd17b3 Knockout Mice Serve As A Model To Define Mechanisms Behind The Altered Endocrine Phenotype Of Patients With Hsd17b3 Mutations
por: Poutanen, Matti, et al.
Publicado: (2019)

Insights in 17β-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation
por: Negri, Matthias, et al.
Publicado: (2010)

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease
por: Dong, Xiaoyu, et al.
Publicado: (2023)

Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer
por: Kraft, Peter, et al.
Publicado: (2005)

Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3
por: Islam, Mohammad Sayful, et al.
Publicado: (2021)

The Peroxisomal Localization of Hsd17b4 Is Regulated by Its Interaction with Phosphatidylserine
por: Lee, Sang-Ah, et al.
Publicado: (2021)

Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter
por: Yang, Song-Yu, et al.
Publicado: (2013)

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer
por: Huang, Huichao, et al.
Publicado: (2020)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer
por: Kruse, Megan L., et al.
Publicado: (2021)

Differential but Concerted Expression of HSD17B2, HSD17B3, SHBG and SRD5A1 Testosterone Tetrad Modulate Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Neural expression and post-transcriptional dosage compensation of the steroid metabolic enzyme 17β-HSD type 4
por: London, Sarah E, et al.
Publicado: (2010)

Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer’s Disease Treatment
por: Aitken, Laura, et al.
Publicado: (2019)

Synthesis of novel 13α-estrone derivatives by Sonogashira coupling as potential 17β-HSD1 inhibitors
por: Bacsa, Ildikó, et al.
Publicado: (2017)

Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study
por: Hernández-López, Hiram, et al.
Publicado: (2020)

Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer’s Disease Treatment
por: Schmidt, Monika, et al.
Publicado: (2020)

Application of particle swarm optimization to understand the mechanism of action of allosteric inhibitors of the enzyme HSD17β13
por: Ford, Amy, et al.
Publicado: (2023)

Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1
por: Herman, Bianka Edina, et al.
Publicado: (2019)

The Mitochondrial Enzyme 17βHSD10 Modulates Ischemic and Amyloid-β-Induced Stress in Primary Mouse Astrocytes
por: Metodieva, Vanya, et al.
Publicado: (2022)

Structural Basis for Species Specific Inhibition of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Computational Study and Biological Validation
por: Klein, Tobias, et al.
Publicado: (2011)

ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models
por: Guo, Shanchun, et al.
Publicado: (2018)

The effects of dexamethasone on 17 [Formula: see text]-HSD1 levels at the rat optic nerve
por: Liu, Chuanzhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ttq4ghrea6uvqn0sh7dhm3qte9